Cancer Institute

Medical and Haemato Oncology

About the Speciality

The Division of Medical Oncology and Haematology at Medanta Cancer Institute provides the specialised and multidisciplinary approach for the treatment of breast, lung, brain, thyroid and inherited cancers among others. The line of treatment and techniques that the institute uses include chemother...

A word from our leaders

What we treat?

At Division of Medical Oncology and Haematology of Medanta, we invest our efforts, time, and expertise to detect and treat various types of cancer.

Our holistic approach to treat you

While encompassing the overall mission of Medanta, the particular goals of the Department of Medical Oncology and Haemato-Oncology are to deliver advanced oncology care in a supportive and compassionate way to all our patients and to advance the t...

Consult with experienced doctors

Utilize cutting-edge technology

  • PET Scan

    A positron emission tomography (PET) is a diagnostic test that allows the doctor to check for diseases in your body. The scan uses a special dye that has radioactive tracers. These tracers are injected into a vein in your arm. Your organs and tissues then absorb the tracer. When highlighted under a PET scanner, the tracers help your doctor to see how well your organs and tissues are working. The PET scan can measure blood flow, oxygen use, glucose metabolism (how your body uses sugar), and much more.

  • DEXA Scan

    A dual-energy X-ray absorptiometry or a DEXA (DXA) scan is a bone density scan and is performed to diagnose osteoporosis, a disease that makes the bones very weak and cause them to break easily. DEXA scans are far more effective than general X-rays in identifying the density of bones.

Avail advanced treatment and procedures

  • Bone Marrow and Stem Cell Transplant

    A bone marrow transplant is a procedure to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Bone marrow transplant is used to treat cancers such as leukaemia, lymphoma, myelodysplasia and multiple myeloma. A stem cell transplant is usually done after the radiation therapy is complete.

  • Fibriadenoma Breast Excision

    Fibroadenomas are common benign tumours of the breast. They are made up of an overgrowth of both the glandular and supporting tissues of the breast. Most often found in women between the ages of 15 and 35, fibroadenomas are affected by women’s hormone levels and can grow larger during pregnancy or smaller after menopause. Whilst you are asleep a cut (incision) is made in the breast over the area where the fibroadenoma can be felt. Alternatively, the cut may be made around the areola or within the fold of the breast. The wound is closed with stitches or glue.

  • Chemotherapy

    Chemotherapy is a drug treatment that uses powerful chemicals to kill fast-growing cells in your body. Chemotherapy is most often used to treat cancer, since cancer cells grow and multiply much more quickly than most cells in the body. Many different chemotherapy drugs are available. Chemotherapy drugs can be used alone or in combination to treat a wide variety of cancers. Though chemotherapy is an effective way to treat many types of cancer, chemotherapy treatment also carries a risk of side effects. Some chemotherapy side effects are mild and treatable, while others can cause serious complications.

  • Biological Therapy

    Biological Therapy is a type of treatment in which body’s immune system is used to kill the cancer cells. It is used in treating many types of cancers to lower the growth of tumour cells and prevent it from growing further. Biological therapy for cancer often causes fewer toxic side effects than other cancer treatments.

  • Targeted therapy

    Targeted therapy is a type of medical treatment for cancer in which the differences between normal cells and cancer cells are treated using targeted drugs. Many targeted drugs go after the cancer cells’ inner workings – the programming that makes them different from normal, healthy cells while leaving most healthy cells alone. Targeted cancer therapies are expected to be more effective than older forms of treatments and less harmful to normal cells.

Why choose Medanta?

With an objective of converting the Medanta Cancer Institute to a centre of excellence and focusing on a “Patient First” approach, Medanta has formed the Disease Management Group (DMG) way to cancer care. In this approach for each type of cancer, a specific multidisciplinary group of specialists that includes medical oncologists, radiation oncologists, surgical oncologists, pathologists, radiologists and physiologists meet together in a tumour board setting to discuss complex cases and debate the best possible course of treatment for the patient.

Success stories at Medanta

Read about how we have been successfully treating some of the most advanced diseases which our patients have been suffering from.

All patient's stories

What's new

At Medanta, our team of doctors and staff are actively involved in community and medical advancement. Take a closer look at what the Medical Oncology team at Medanta is upto.

Active Programs Workshops

Research & Publications

  • Nilotinib as first line therapy for Chronic Myeloid Leukemia - Indian Journal of Cancer , 2011
    Click here for Publications Link
  • Management of primary and metastatic triple negative breast cancer: perceptions of oncologists from India - Indian Journal of Cancer , 2011
    Click here for Publications Link
  • Management of Malignant Germ Cell Tumours of Ovary - Indian Journal of Cancer
  • Synchronous esophageal carcinoma with Non-Hodgkin's lymphoma, problems with management - Indian Journal of Cancer
Have a question? Call us +91-124-4141414